Adalimumab/etanercept/infliximabAseptic meningitis: 4 case reports

被引：0

|

作者：

机构：

来源：

Reactions Weekly | 2017年 / 1643卷 / 1期

关键词：

D O I：

10.1007/s40278-017-27488-5

中图分类号：

学科分类号：

摘要：

引用

收藏

页码：15 / 15

相关论文

共 50 条

[41] Adalimumab/etanercept/secukinumabVarious toxicities: 3 case reports
Reactions Weekly, 2023, 1953 (1) : 16 - 16
[42] Adalimumab/etanercept/infliximabSalmonella infections: 17 case reports
Reactions Weekly, 2010, 1302 (1) : 6 - 6
[43] Adalimumab/etanercept/infliximabCutaneous psoriasis: 12 case reports
Reactions Weekly, 2008, 1210 (1) : 5 - 5
[44] Adalimumab/etanercept/infliximabKeratoderma blenorrhagicum: 3 case reports
Reactions Weekly, 2008, 1212 (1) : 5 - 5
[45] Adalimumab/etanercept/infliximabVarious toxicities: 41 case reports
Reactions Weekly, 2010, 1297 (1) : 7 - 7
[46] Adalimumab/etanercept/methotrexateCutaneous leishmaniasis: 6 case reports
Reactions Weekly, 2019, 1769 (1) : 20 - 20
[47] Adalimumab/etanercept/infliximabVarious toxicities: 9 case reports
Reactions Weekly, 2018, 1698 (1) : 22 - 22
[48] Adalimumab/etanercept/infliximabActive tuberculosis: 5 case reports
Reactions Weekly, 2016, 1591 (1) : 17 - 17
[49] Adalimumab/etanercept/infliximabVarious toxicities: 13 case reports
Reactions Weekly, 2022, 1902 (1) : 20 - 20
[50] Adalimumab/etanercept/infliximabSkin eruptions: 9 case reports
Reactions Weekly, 2010, 1319 (1) : 8 - 8

← 1 2 3 4 5 →